Major Depressive Disorder Clinical Trial
Official title:
Electronic-Measurement Based Care (e-MBC) for Major Depressive Disorder (MDD)
The pilot study will evaluate whether electronic-Measurement Based Care (e-MBC) using the UT Southwestern MyChart personal health record is feasible, associated with patient and health care team satisfaction, and improves treatment outcomes compared to a standard treatment model. The project will be conducted in the Simmons Cancer Center Clinic at the University of Texas Southwestern Medical Center, Dallas as a collaborative effort between the Departments of Psychiatry, Oncology, and Family and Community Medicine. The primary patient population will include adults with significant depression and/or starting an antidepressant treatment and/or experiencing a treatment change. The study will compare two groups, an e-MBC group and an office-based standard care MBC group. Study staff will explain the study to the patients, specifically explaining that study participants will receive either office-based MBC or e-MBC. Eligible participants must be willing to receive either form of treatment monitoring. Participating patients will be randomly assigned to receive either e-MBC or office-based MBC. In the e-MBC group once a month the study nurse will send a prompt from the participating patients treating physician requesting the patient to use the MyChart system to fill-out the MBC scales. Beyond these monthly assessments, patients will be encouraged to utilize the MyChart MBC assessments (e-MBC) at any time to communicate with their physician. Patients experiencing difficulties using the e-MBC system will be given additional instruction by the study nurse. Patients and physicians will be trained in the use of the eMBC system. In the office-based MBC group the study nurse will schedule monthly treatment visits and request the patient call as needed to report symptoms. The evaluation period will be 6 months.
Major Depressive Disorder (MDD) is a serious, debilitating illness that affects persons of
all ages, races, and socioeconomic backgrounds. Despite the availability of new and effective
treatments over the last 20 years, recent evidence continues to demonstrate high rates of
inadequate antidepressant medication treatment in practice settings. Practitioners vary
widely in how they assess treatment outcomes, including symptoms, function, side-effect
frequency and burden. In contrast to other chronic medical conditions such as diabetes
mellitus, back/neck problems, or hypertension, clinicians treating patients with depression
do not routinely evaluate measurement-based care (MBC) treatment parameters. MBC provides an
essential framework for physicians to approach depression treatment consistent with their
approach for other common disorders. MBC is an effective means to provide patient-centered
care for MDD, personalizing treatment decisions based on patient progress and their ability
to tolerate the medication.
A key barrier to patient adherence with MBC treatment is that the approach requires patients
to return to the clinic for several follow-up visits. The necessity of treatment visits
varies widely among patients. Thus far, physicians using MBC for the treatment of MDD do not
have a complete set of tools that are practical to use and allow treatment to be truly
personalized patient-centered care.
One solution to this problem is to use an enhanced electronic personal health record, such as
the MyChart system. This system could be easily modified to include the central elements of
MBC for depression to allow for the systematic assessment of a patient's depressive symptom
severity, antidepressant tolerability, and adherence to treatment in a timely fashion. This
information would be available to allow the physician to provide patient-centered care by
utilizing standardized assessment to personalize treatment for depression. The proposed
electronic-MBC (e-MBC) addresses a critical gap in depression treatment by providing
regularly-scheduled drug monitoring and continuity of care, in the face of limited patient
and clinic resources.
Information technology (IT) systems have been effectively integrated into the medical
treatment of patients but have yet to have substantial impact at the point-of-care. Applying
e-MBC methods allows physicians to utilize existing information technology systems to improve
depression treatment at the point-of-care. The key features of the proposed e-MBC approach
are that it can be seamlessly integrated into standard clinical practice, and requires no
additional IT knowledge or training to be effectively utilized by physicians and clinical
staff.
In this pilot study the investigators will compare standard treatment (office based
antidepressant management) to a group receiving scheduled electronic MBC assessments via an
enhanced personal health record system (e-MBC). To date, no one has published feasibility
studies evaluating the use of personal health records for measurement-based care of
depression patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
||
Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
Completed |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
Recruiting |
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A | |
Terminated |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
N/A | |
Recruiting |
NCT05892744 -
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
|
Phase 4 | |
Recruiting |
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 | |
Active, not recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
Completed |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
Recruiting |
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A | |
Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
Recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
Recruiting |
NCT05895747 -
5-HTP and Creatine for Depression R33 Phase
|
Phase 2 | |
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Recruiting |
NCT05813093 -
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
|
N/A | |
Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
Recruiting |
NCT06145594 -
EMA-Guided Maintenance TMS for Depression
|
N/A | |
Recruiting |
NCT06026917 -
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
|
Phase 4 |